Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol for Glucocorticoid-induced Bone Loss in RA
NCT06385093Phase 4Not yet recruiting
- Sponsor
- Chinese SLE Treatment And Research Group
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eldecalcitol in glucocorticoid-induced osteoporosis (GIOP), sponsored by Chinese SLE Treatment And Research Group. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
eldecalcitol
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT06385093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385093.